Wave Life Sciences (WVE) EBITDA (2014 - 2026)
Wave Life Sciences (WVE) EBITDA from Sep 30, 2014 to Mar 31, 2026. The TTM Wave Life Sciences (WVE) EBITDA is -$193M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Wave Life Sciences (WVE) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +58.56% |
| 3 Years TTM | +9.19% |
| 5 Years TTM | +6.86% |
| 10 Years TTM | +23.66% |
| All Time TTM | +30.59% |
Annual EBITDA change of Wave Life Sciences (WVE)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$30M | -85.63% |
| 2025 | -$212M | +98.99% |
| 2024 | -$107M | +69.06% |
| 2023 | -$63M | -59.65% |
| 2022 | -$156M | +30.64% |
| 2021 | -$120M | -17.71% |
| 2020 | -$145M | -27.63% |
| 2019 | -$201M | +30.39% |
| 2018 | -$154M | +53.57% |
| 2017 | -$100M | +82.45% |
| 2016 | -$55M | +193.80% |
| 2015 | -$19M | +265.95% |
| 2014 | -$5.11M | +54.85% |
| 2013 | -$3.30M | N/A |
Comparison Wave Life Sciences (WVE) five years EBITDA CAGR with competitors
Wave Life Sciences (WVE) five years EBITDA CAGR is 6.86%.